Institute for Biomedical and Pharmaceutical Research

Recent papers from Institute for Biomedical and Pharmaceutical Research

1. Long-Term Survival of Borna Disease Virus 1 (BoDV-1)-Encephalitis: An Exceptional Case with Valuable Insights for Pathophysiology and Disease ManagementInfectious Diseases and Therapy · 2026
2. A fast method for the quantification of bortezomib in serum and rat nervous tissue by liquid chromatography tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis · 2026
3. Pharmacokinetics of cefiderocol during prolonged intermittent kidney replacement therapy in two patients with septic shockJournal of Antimicrobial Chemotherapy · 2025
4. Antibacterial therapy in central nervous system infections – breakpoints versus minimal inhibitory concentrations related to body fluid levelsInfection · 2025
5. DNA-Encoded Library Screening Uncovers Potent DNMT2 Inhibitors Targeting a Cryptic Allosteric Binding SiteiScience · 2025
6. A Differential Proteomic Analysis on Patient Sera with Neuromyelitis Spectrum Disorders (NMOSD) and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) Suggested Shared and Distinct Disease MechanismsJournal of Proteome Research · 2025
7. Monitoring Plasma Concentrations of Intravenously Administered Fosfomycin to Prevent Drug-Related Adverse Events: A Retrospective Observational StudyAntibiotics · 2025
8. Bridging to Transplant: TDM-guided Outpatient Dalbavancin Therapy in Chronic Granulomatous Disease With Deep-seeded Inoperable Abscesses Over 11 MonthsOpen Forum Infectious Diseases · 2025
9. Understanding the low inter-rater agreement on aggressiveness on the Linux Kernel Mailing ListJournal of Systems and Software · 2025
10. Targeted and untargeted screening for impurities in losartan tablets marketed in Germany by means of liquid chromatography/high resolution mass spectrometryJournal of Pharmaceutical and Biomedical Analysis · 2024
11. Understanding adefovir pharmacokinetics as a component of a transporter phenotyping cocktailEuropean Journal of Clinical Pharmacology · 2024
12. Remission definitions guiding immunosuppressive therapy in rheumatoid arthritis: which is best fitted for the purpose?RMD Open · 2024
13. Clinical and demographic factors affecting trough levels of isavuconazole in critically ill patients with or without COVID‐19Mycoses · 2023
14. Pharmacokinetics of Nirmatrelvir and Ritonavir in COVID-19 Patients with End-Stage Renal Disease on Intermittent HemodialysisAntimicrobial Agents and Chemotherapy · 2022
15. Caffeine, Paraxanthine, Theophylline, and Theobromine Content in Human MilkNutrients · 2022
16. Isavuconazole therapeutic drug monitoring in critically ill ICU patients: A monocentric retrospective analysisMycoses · 2022
17. Structural and Enzymological Evidence for an Altered Substrate Specificity in Okur-Chung Neurodevelopmental Syndrome Mutant CK2αLys198ArgFrontiers in Molecular Biosciences · 2022
18. Impurity profiling of bisoprolol fumarate by liquid chromatography-high-resolution mass spectrometry: A combination of targeted and untargeted approaches using a synthesis reaction matrix and general unknown comparative screeningJournal of Chromatography Open · 2021
19. Methylprednisolone Plasma Concentrations During Cardiac Surgery With Cardiopulmonary Bypass in Pediatric PatientsFrontiers in Cardiovascular Medicine · 2021
20. Central nervous system infections and antimicrobial resistance: an evolving challengeCurrent Opinion in Neurology · 2021